Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-99-000047
Filing Date
1999-02-12
Accepted
1999-02-12 00:00:00
Documents
1
Group Members
GENETIC THERAPY, INC.NOVARTIS INCNOVARTIS PHARMA AGNOVARTIS PHARMACEUTICALS CORPORATION

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 15129
  Complete submission text file 0000947871-99-000047.txt   17082
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 6199319200
ISIS PHARMACEUTICALS INC (Subject) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-41771 | Film No.: 99534617
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND V8
Business Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND 2128302413
NOVARTIS INC (Filed by) CIK: 0001030617 (see all company filings)